Glypican-3 expression and its relationship with recurrence of HCC after liver transplantation

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 19

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

393

HTML

3267

Figures (1-4)

138

Tables (1-2)

122

Sum=3920

May 21, 2012 (publication date) through May 22, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. May 21, 2012; 18(19): 2408-2414
Published online May 21, 2012. doi: 10.3748/wjg.v18.i19.2408

Table 1 Clinicopathological features of the study population (n = 31)

Gender (Male/female)	29/2
Age (mean/range) (yr)	49/37-62
Primary liver disease (HBV cirrhosis/HCV cirrhosis)	30/1
TNM stage (I-II/III-IVa)	12/19
Milan criteria (within/beyond)	15/16
Tumor diameter (< 5 cm/≥ 5 cm)	16/15
Tumor number (< 3/≥ 3)	26/5
Vascular invasion (present/absent)	16/15
Serum AFP ( ≤ 20 μg/L/> 20 μg/L)	11/20
Histological differentiation (good/moderate and poor)	6/25

HBV: Hepatitis B virus; HCV: Hepatitis C virus; TNM: Tumor, node and metastasis; AFP: α fetoprotein.

Citation: Wang YL, Zhu ZJ, Teng DH, Yao Z, Gao W, Shen ZY. Glypican-3 expression and its relationship with recurrence of HCC after liver transplantation. World J Gastroenterol 2012; 18(19): 2408-2414
URL: https://www.wjgnet.com/1007-9327/full/v18/i19/2408.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i19.2408